乳癌(HER2-, HER2+)：疫学的予測（～2023）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
2.3 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 10
3.2.1 A family history of breast cancer and BRCA1/2 gene mutations significantly increase the breast cancer risk 12
3.2.2 Reproductive hormonal factors influence the risk of breast cancer 12
3.2.3 Modifiable lifestyle-related factors increase the risk of mortality in breast cancer patients 14
3.2.4 Screening programs have been shown to reduce breast cancer mortality, although the benefits need to be carefully weighed against the risks 16
3.3 Global Trends 19
3.3.1 Incidence 19
3.3.2 Prevalence and Survival 25
3.4 Forecast Methodology 29
3.4.1 Sources Used 31
3.4.2 Sources Not Used 35
3.4.3 Forecast Assumptions and Methods 36
3.5 Epidemiological Forecast for Breast Cancer (2013-2023) – Diagnosed Incident Cases 39
3.5.1 Diagnosed Incident Cases of Breast Cancer 39
3.5.2 Diagnosed Incident Cases of Breast Cancer by Age 41
3.5.3 Diagnosed Incident Cases of Breast Cancer by Menopausal Status 43
3.5.4 Diagnosed Incident Cases of Breast Cancer Segmented by Stage at Diagnosis 45
3.5.5 Age-Standardized Diagnosed Incidence Rate of Breast Cancer 46
3.6 Epidemiological Forecast for Breast Cancer (2013-2023) — Diagnosed Prevalent Cases 47
3.6.1 Five-Year Diagnosed Prevalent Cases of Breast Cancer 47
3.6.2 Five-Year Diagnosed Prevalent Cases by Menopausal Status 49
3.6.3 Five-Year Diagnosed Prevalent Cases by Hormone Receptor Subtypes 50
3.7 Discussion 52
3.7.1 Epidemiological Forecast Insight 52
3.7.2 Limitations of the Analysis 54
3.7.3 Strengths of the Analysis 55
4 Appendix 57
4.1 Bibliography 57
4.2 About the Authors 66
4.2.1 Epidemiologists 66
4.2.2 Reviewers 66
4.2.3 Acting Director of Epidemiology 67
4.2.4 Global Head of Healthcare 67
4.3 About GlobalData 68
4.4 About EpiCast 68
4.5 Disclaimer 69